D.E. Shaw & Co
GRNA

D.E. Shaw & Co’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

D.E. Shaw & Co’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-403,120
Closed -$4M – 6125
2021
Q4 		$4M Buy
403,120
+121,019
+43% +$1.2M ﹤0.01% 2639
2021
Q3 		$2.79M Buy
282,101
+20,818
+8% +$204K ﹤0.01% 2699
2021
Q2 		$2.56M Buy
+261,283
New +$2.55M ﹤0.01% 2685

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCMH
Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

D.E. Shaw & Co's GRNA Position: Q1 2022 in Review

D.E. Shaw & Co sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2022, closing a stake of 403,120 shares — an estimated $4M sold.

D.E. Shaw & Co first reported a position in GRNA in Q2 2021 and held it in 3 quarters. The position peaked at $4M in Q4 2021. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

  • D.E. Shaw & Co reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 403,120 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2022, an estimated $4M.
  • D.E. Shaw & Co first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $4M in Q4 2021.
  • 39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.